Embecta Corp (EMBC)
13.82
-0.18
(-1.29%)
USD |
NASDAQ |
Nov 22, 16:00
13.86
+0.04
(+0.33%)
After-Hours: 20:00
Embecta Shareholders Equity (Quarterly): -763.70M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -763.70M |
March 31, 2024 | -769.60M |
December 31, 2023 | -793.50M |
September 30, 2023 | -821.70M |
June 30, 2023 | -809.40M |
March 31, 2023 | -822.60M |
Date | Value |
---|---|
December 31, 2022 | -836.10M |
September 30, 2022 | -891.40M |
June 30, 2022 | -847.60M |
March 31, 2022 | -967.50M |
December 31, 2021 | 550.50M |
September 30, 2021 | 594.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-967.50M
Minimum
Mar 2022
594.30M
Maximum
Sep 2021
-598.19M
Average
-815.55M
Median
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Abbott Laboratories | 39.80B |
Nevro Corp | 273.64M |
iRhythm Technologies Inc | 71.77M |
Inari Medical Inc | 434.76M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.268B |
Total Liabilities (Quarterly) | 2.031B |
Debt to Equity Ratio | -2.096 |
Current Ratio | 2.107 |
Net Debt Paydown Yield | 0.14% |